As it has been reported that PD-L1 expression in tumor patients is linked to a better response to immunotherapy [13] and we found upregulated PDL1 expression in the TU region of our patient cohort, we next examined the effect of in vivo PD-L1 blockade in our murine model of lung cancer. Here, CD274 is linked to lung cancer.